School-Based Treatment With ACT to Reduce Transmission
NCT02009215
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10746
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
Dihydroartemisinin-piperaquine (DP)
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
[object Object]
[object Object]
[object Object]